C
Charles L. Feldman
Researcher at Brigham and Women's Hospital
Publications - 87
Citations - 8278
Charles L. Feldman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Coronary artery disease & Intravascular ultrasound. The author has an hindex of 32, co-authored 87 publications receiving 7612 citations. Previous affiliations of Charles L. Feldman include Worcester Polytechnic Institute & Harvard University.
Papers
More filters
Journal ArticleDOI
Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.
Hisako Tsuji,Martin G. Larson,Ferdinand J. Venditti,Emily S. Manders,Jane C. Evans,Charles L. Feldman,Daniel Levy +6 more
TL;DR: The estimation of HRV by ambulatory monitoring offers prognostic information beyond that provided by the evaluation of traditional cardiovascular disease risk factors, as well as other relevant risk factors.
Journal Article
Reduced Heart Rate Variability and Mortality Risk in an Elderly Cohort : the Framingham Heart Study
Hisako Tsuji,Ferdinand J. Venditti,Emily S. Manders,Jane C. Evans,Martin G. Larson,Charles L. Feldman,Daniel Levy +6 more
TL;DR: The estimation of heart rate variability by ambulatory monitoring offers prognostic information beyond that provided by the evaluation of traditional risk factors.
Journal ArticleDOI
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study.
Hisako Tsuji,Ferdinand J. Venditti,Emily S. Manders,Jane C. Evans,Martin G. Larson,Charles L. Feldman,Daniel Levy +6 more
TL;DR: In this article, the first 2 hours of ambulatory ECG recordings obtained on original subjects of the Framingham Heart Study attending the 18th biennial examination were reprocessed to assess heart rate variability.
Journal ArticleDOI
Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION Study.
Peter Stone,Shigeru Saito,Saeko Takahashi,Yasuhiro Makita,Shigeru Nakamura,Tomohiro Kawasaki,Akihiko Takahashi,Takaaki Katsuki,Sunao Nakamura,Atsuo Namiki,Atsushi Hirohata,Toshiyuki Matsumura,Seiji Yamazaki,Hiroyoshi Yokoi,Shinji Tanaka,Satoru Otsuji,Fuminobu Yoshimachi,Junko Honye,Dawn Harwood,Martha Reitman,Ahmet U. Coskun,Michail I. Papafaklis,Charles L. Feldman +22 more
TL;DR: In this article, a three-vessel vascular profiling (2.7 arteries per patient) was performed at baseline in 506 patients with acute coronary syndrome treated with a percutaneous coronary intervention and in a subset of 374 (74%) consecutive patients 6 to 10 months later to assess plaque natural history.
Journal ArticleDOI
Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood Vessels
Netanel Korin,Mathumai Kanapathipillai,Benjamin D. Matthews,Marilena Crescente,Marilena Crescente,Alexander Brill,Alexander Brill,Tadanori Mammoto,Kaustabh Ghosh,Samuel Jurek,Sidi A. Bencherif,Sidi A. Bencherif,Deen Bhatta,Ahmet U. Coskun,Charles L. Feldman,Denisa D. Wagner,Denisa D. Wagner,Donald E. Ingber,Donald E. Ingber,Donald E. Ingber +19 more
TL;DR: A biomimetic strategy that uses high shear stress caused by vascular narrowing as a targeting mechanism—in the same way platelets do—to deliver drugs to obstructed blood vessels offers a potential new approach for treatment of life-threatening diseases that result from acute vascular occlusion.